Press release announces that polatuzumab with R-CHP vs. RCHOP in front line DLBCL met its primary endpoint by demonstrating significantly improved and clinically meaningful progression-free survival. There is limited information in the press release, but if a true significant improvement would be the first combo to beat RCHOP in >20 years.
Doctoral candidate David Versluis successfully simulated an infant gut. This is crucial for research on improvements in formula milk. Currently, such research primarily relies on…
Recommendations for Worker Protection and Use of Personal Protective Equipment (PPE) to Reduce Exposure to Highly Pathogenic Avian Influenza A H5 Viruses – CDC
Generative AI is entering the corporate application fields and bringing in practical challenges.
Al Royse rolls up his sleeves to contribute meaningfully to the American Heart Association, where he has volunteered for more than two decades.
Devin Alexander – Chef for NBC’s Biggest Loser and author, shares her personal perspective as a chef in this blog entry that helps beginners learn…
On January 7, 2024, our cardiac electrophysiology community lost Bruce L. Wilkoff, MD, one of the most impactful and pioneering members of the Heart Rhythm…
Background and ObjectivesThis cross-sectional observational study retrospectively examined clinical data collected from adolescents and young adults (AYAs) seeking care in a specialty headache clinic. We…
Iskowitz has won Best Range of Work by a Single Author for three years running.
More than 130 staff and students signed a letter condemning what they call an “arbitrary and heavy-handed response” by the private university. Activists plan to…
The USDA order mandating H5N1 bird flu testing in dairy cows is less stringent than initially described by the agency.
